Blog

Can GLP-1 Medications Lead to Lower Food Expenses?

Can GLP-1 Medications Lead to Lower Food Expenses?

As for the current economy, controlling the amount of money spent on groceries is one of the most crucial problems for many households. Surprisingly, some people who take GLP-1 receptor agonists, such as semaglutide and tirzepatide, have noted changes in their eating behavior that may result in decreased food expenditure. These medications, initially created for type 2 diabetes and weight management, operate by mimicking a hormone in the body that controls hunger and glucose levels. This leads to the users of these medications feeling less hungry and more full, which may affect their food buying behavior in some way.

How GLP-1 Medications May Affect Food Expenditure
Current studies show that GLP-1 medication users may spend less money on food in total. Although the experiences are different, some patterns have been identified:

  • Overall Food Purchases Decreased: Some research shows that households with at least one GLP-1 user spent about 5.5% less on groceries in the first six months of the medication.

  • Decreased Impulse and Processed Food Purchases: Some people note that they buy fewer snacks, sweets, and processed foods that are also expensive. Instead, they may decide to eat more nutrient-dense foods and buy only the required products instead of buying more luxuries.

  • Less Spending on Eating Out: Study results also show changes in the way people spend their money, and GLP-1 users eat out less often. This may also help save money as the fast food and restaurant expenses are reduced.

Nutrient-Dense Foods
Although some users of semaglutide and tirzepatide may state that they spend less on groceries, they may also switch to buying smaller quantities of better-quality foods. Common changes include:

  • More Fresh Produce and Protein: People may decide to eat smaller portions of better-quality foods like fresh vegetables, lean proteins, and whole grains.

  • Less Trips to the Store: Less appetite may result in fewer trips to the store, which in turn helps in avoiding buying more foods that may go to waste.

Important Aspects to Consider When Analyzing the Cost Savings
Although there may be a decrease in the grocery bills, it is crucial to take into consideration the price of the GLP-1 medications. The cost of name brand GLP-1's (Wegovy, Ozempic, Mounjaro) is as high as $1,500 per month without insurance. However, Ahvina offers a more affordable way to get compounded GLP-1 medications (semaglutide, tirzepatide) compared to the expensive brand medicines.
Ahvina has also come up with flexible payment plans to make the service more accessible. Customers are eligible for HSA reimbursement, which makes it easier to incorporate these treatments into their financial plans. Also, Ahvina has partnered with Affirm to enable clients to make monthly payments that are most comfortable for them, thus reducing the financial pressure of the initial costs.

The Bottom Line
GLP-1 drugs including semaglutide and tirzepatide may influence appetite and food buying behavior, but like any other medication, results will vary from one person to another. Some patients may observe a decrease in their grocery bill as well as the bill for dining out, while others may notice no change in their expenses. If you are thinking about taking these medicines, you should talk to your doctor about how to incorporate them into your overall plan for your health and finances. Head over to Ahvina.com to begin your journey to good health!

Sources:



Read more